Current Oncology, Vol 23, Suppl 1 - Now Published!


Original Cancer Costing Research Using Canadian Data

Multimed Inc. is pleased to announce that Current Oncology has published a supplement dedicated to cancer costing research using Canadian data. Co-edited by Dr. Nicole Mittmann (Cancer Care Ontario, Toronto, ON) and Dr. Claire de Oliveira (Centre for Addiction and Mental Health, Toronto, ON), the manuscripts in this supplement use a wide array of methods and Canadian data sources to deal with various disease sites and relevant issues in cancer care. In particular, they include studies relating to breast cancer (analysis of the cost implications of unwarranted imaging of patients, and an economic evaluation of a novel technology) and cervical cancer (estimation of utilization and costs, and use of a simulation model to evaluate cytology compared with primary human papillomavirus dna screening). Other studies focus on the estimation of drug and pathology cost avoidance in clinical trials and the cost trajectories of cancer patients over time. Finally, two studies provide an overview of the trends in costs for systemic therapy, home nursing, and hospitalizations for end-of-life care across the country.

We would like to thank all of the contributing authors for their work on this special supplement. We would also like to send a special thank you to Dr. Nicole Mittmann and Dr. Claire de Oliveira for their hard work and dedication as well as the Canadian Partnership Against Cancer for their support.

To view the full Table of Contents, please click here.